AI Article Synopsis

  • - A 2021 international survey revealed a lack of information on master's programs in pharmaceutical sciences, capturing responses from 96 universities across 23 countries, primarily from India, the US, and Japan.
  • - Most master's programs are full-time and last two years, with 97% incorporating research components, and 3% being examination-based; programs in Asia and Europe are generally larger, while North American programs host more international students.
  • - Graduates in Asia predominantly join the pharmaceutical industry (70%), whereas North America and Europe have lower percentages (28-36%) entering industry careers and a higher proportion continuing to Ph.D. programs; funding remains a key challenge for faculty and students.

Article Abstract

Information on master's programs in the pharmaceutical sciences is lacking; this manuscript addresses this gap in the literature, by reporting on the results of an international survey performed in 2021 of master's programs in the pharmaceutical sciences offered at Schools/Colleges of Pharmacy. Ninety-six responses were received from universities from 23 countries, with the greatest number of responses obtained from India, followed by the United States and Japan. Master's programs in the pharmaceutical sciences are generally full time and 2 years in duration. Only 3% of programs were reported to be examination-based, while the remaining 97% had a research component with 70% of programs having a thesis defense with external and/or internal examiners. Master's programs tended to be larger in Asia and Europe than in North America; as well, programs in North America tended to have more international students. Didactic coursework was included in 96% of master's programs in North America, but only in 38% of Asian and 58% of European programs. The predominant placement of graduates from master's programs in Asia was in the pharmaceutical industry (70%); this contrasted with programs in Europe, Africa and North America where 28-36% enter careers in the pharmaceutical industry and higher percentages enter Ph.D. programs. The major challenge identified by programs was funding of faculty and of graduate students, although decreasing career opportunities was identified as a challenge in Asia and Africa.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.xphs.2022.07.003DOI Listing

Publication Analysis

Top Keywords

master's programs
24
programs pharmaceutical
16
pharmaceutical sciences
16
north america
16
programs
14
international survey
8
programs north
8
pharmaceutical industry
8
master's
7
pharmaceutical
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!